Biosynex SA (ALBIO.PA)
EUR 1.62
(-0.25%)
EUR 1.62
(-0.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -9.65 Million | 4.94 Million | 109.83 Million | 31.63 Million | 1.1 Million | 467.11 Thousand |
| Net Income | -35.61 Million | 15.61 Million | 104 Million | 31.36 Million | 1.09 Million | 542.89 Thousand |
| Depreciation & Amortization | 13.45 Million | 16.36 Million | 6.61 Million | 6.64 Million | 552 Thousand | 467.11 Thousand |
| Deferred income taxes | -1.99 Million | -337.65 Thousand | 504.22 Thousand | 201.75 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 12.51 Million | -37.26 Million | 577.57 Thousand | -7.18 Million | - | - |
| Other non-cash items | 6.45 Million | 43.29 Million | 11.36 Million | 13.88 Million | -1.09 Million | -542.89 Thousand |
| Investing Cash Flow | -54.81 Million | -39.08 Million | -28.96 Million | -7.92 Million | - | - |
| Investments in PPE | -39.54 Million | -30.08 Million | -19.01 Million | -9.11 Million | - | - |
| Acquisitions | -16.05 Million | 51.83 Thousand | 42.17 Thousand | 1.19 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 706 Thousand | -9.05 Million | -9.98 Million | -1.00 | - | - |
| Financing Cash Flow | 5.17 Million | -10.81 Million | 14.39 Million | 10.61 Million | - | - |
| Debt repayment | -7.58 Million | -12.08 Million | -16.83 Million | -6.01 Million | - | - |
| Dividends payments | - | -20.44 Million | -1.93 Million | - | - | - |
| Common Stock Repurchased | -3.21 Million | -1.73 Million | -20.08 Million | - | - | - |
| Common Stock Issuance | - | -32.00 | 19.42 Million | 4.44 Million | - | - |
| Other Financing Activities | 808 Thousand | 23.45 Million | 33.81 Million | 12.18 Million | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 14.5 Million | -37.26 Million | 577.57 Thousand | -7.18 Million | - | - |
| Cash at beginning of period | 79.46 Million | 132.03 Million | 36.83 Million | 1.85 Million | 1.84 Million | 2.01 Million |
| Cash at end of period | 20.16 Million | 87.17 Million | 132.03 Million | 36.83 Million | 1.85 Million | 1.84 Million |
| Capital Expenditure | -39.54 Million | -30.08 Million | -19.01 Million | -9.11 Million | - | - |
| Effect of forex changes on cash | - | 90.2 Thousand | -73.49 Thousand | 2.5 Million | - | - |
| Net cash flow / Change in cash | -59.29 Million | -44.86 Million | 95.19 Million | 34.98 Million | 1463.00 | -168.36 Thousand |
| Free Cash Flow | -49.19 Million | -25.13 Million | 90.81 Million | 22.51 Million | 1.1 Million | 467.11 Thousand |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -35.61 Million | -17.55 Million | -19.39 Million | -14.97 Million | 15.61 Million | 30.58 Million |
| Depreciation & Amortization | 13.45 Million | 5.75 Million | 17.08 Million | 10.25 Million | 16.36 Million | 6.11 Million |
| Deferred income taxes | -1.99 Million | -1.89 Million | -103 Thousand | -170.96 Thousand | -337.65 Thousand | -166.68 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 12.51 Million | 16.86 Million | -2.35 Million | -5.28 Million | -37.26 Million | -31.97 Million |
| Other non-cash items | 6.45 Million | -4.6 Million | 28.81 Million | 29.66 Million | 43.29 Million | 13.63 Million |
| Investing Cash Flow | -54.81 Million | -7.35 Million | -47.45 Million | -16.37 Million | -39.08 Million | -22.7 Million |
| Investments in PPE | -39.54 Million | -7.57 Million | -31.96 Million | -10.87 Million | -30.08 Million | -19.2 Million |
| Acquisitions | -16.05 Million | 434 Thousand | 6000.00 | 3832.00 | 51.83 Thousand | 48 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 706 Thousand | -214 Thousand | -15.49 Million | -5.5 Million | -9.05 Million | -3.54 Million |
| Financing Cash Flow | 5.17 Million | -10.54 Million | 15.71 Million | 11.06 Million | -10.81 Million | -21.87 Million |
| Debt repayment | -7.58 Million | -9.78 Million | -17.37 Million | -11.59 Million | -12.08 Million | -496.58 Thousand |
| Dividends payments | - | - | - | - | -20.44 Million | -20.44 Million |
| Common Stock Repurchased | -3.21 Million | -714 Thousand | -2.5 Million | -44.19 Thousand | -1.73 Million | -1.68 Million |
| Common Stock Issuance | - | - | - | - | -32.00 | 1.00 |
| Other Financing Activities | 808 Thousand | -9.83 Million | 852 Thousand | -482.91 Thousand | 23.45 Million | -245.61 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 14.5 Million | 16.86 Million | -2.35 Million | -5.28 Million | -37.26 Million | -31.97 Million |
| Cash at beginning of period | 79.46 Million | 45.29 Million | 87.17 Million | 93.52 Million | 132.03 Million | 132.03 Million |
| Cash at end of period | 20.16 Million | 20.16 Million | 45.31 Million | 87.17 Million | 87.17 Million | 93.52 Million |
| Capital Expenditure | -39.54 Million | -7.57 Million | -31.96 Million | -10.87 Million | -30.08 Million | -19.2 Million |
| Effect of forex changes on cash | - | - | 87.15 Million | -87.15 Million | 90.2 Thousand | 132.1 Million |
| Net cash flow / Change in cash | -59.29 Million | -25.12 Million | -41.85 Million | -6.34 Million | -44.86 Million | -38.51 Million |
| Free Cash Flow | -49.19 Million | -7.11 Million | -42.08 Million | -11.88 Million | -25.13 Million | -13.25 Million |
7022
EPG-R
LMDCF
LUCRF
ALINS
RPTECH